Lupus nephritis Trials in Guangzhou, China
Conditions / Lupus nephritis / Guangzhou, China
Research into Lupus nephritis spans multiple therapeutic approaches and trial phases.
22 total trials for this combination
Showing top 10 of 22 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01714817 | Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis | TERMINATED | PHASE3 |
| NCT04643470 | Zanubrutinib in Participants With Active Proliferative Lupus Nephritis | COMPLETED | PHASE2 |
| NCT05138133 | Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03943147 | An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis | TERMINATED | PHASE2 |
| NCT01639339 | Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis | COMPLETED | PHASE3 |
| NCT05126277 | Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis | RECRUITING | PHASE3 |
| NCT00377637 | A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis. | COMPLETED | PHASE3 |
| NCT04181762 | Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis | TERMINATED | PHASE3 |
| NCT05097989 | Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) | TERMINATED | PHASE2 |
| NCT05680480 | A Study of Telitacicept in Lupus Nephritis | RECRUITING | PHASE2 |